+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

From
Metastatic Head and Neck Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Head and Neck Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Checkpoint-Inhibitor Refractory Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Checkpoint-Inhibitor Refractory Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Chemotherapy-Induced Hearing Loss - Pipeline Insight, 2024 - Product Thumbnail Image

Chemotherapy-Induced Hearing Loss - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Undifferentiated Pleomorphic Sarcoma (UPS) - Pipeline Insight, 2024 - Product Thumbnail Image

Undifferentiated Pleomorphic Sarcoma (UPS) - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Unresectable Melanoma - Pipeline Insight, 2024 - Product Thumbnail Image

Unresectable Melanoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Pediatric Brain Tumors - Pipeline Insight, 2024 - Product Thumbnail Image

Pediatric Brain Tumors - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
ER positive, HER2 negative Breast Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

ER positive, HER2 negative Breast Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
Esophageal Squamous Cell Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Esophageal Squamous Cell Carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 150 Pages
  • Global
From
Waldenstrom's Macroglobulinemia - Pipeline Insight, 2024 - Product Thumbnail Image

Waldenstrom's Macroglobulinemia - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 80 Pages
  • Global
From
Myc Proto Oncogene Protein - Pipeline Insight, 2024 - Product Thumbnail Image

Myc Proto Oncogene Protein - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Head & Neck Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Head & Neck Carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Head and Neck Squamous Cell Carcinoma (HNSCC) - Pipeline Insight, 2024 - Product Thumbnail Image

Head and Neck Squamous Cell Carcinoma (HNSCC) - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
HER+ Gastric Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

HER+ Gastric Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
HER2+ Non Small Cell Lung Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

HER2+ Non Small Cell Lung Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
KRAS Mutant Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

KRAS Mutant Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Metastatic Cutaneous Melanoma - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Cutaneous Melanoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
T-Cell Blood Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

T-Cell Blood Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more